72 related articles for article (PubMed ID: 18199983)
1. Antitumor efficacy of autovaccines prepared from chemoresistant tumor cells with the use of lectin OF B. subtilis B-7025.
Potebnya G; Cheremshenko N; Lisovenko G; Voyekova I; Bazas' V; Todor I; Chekhun V
Exp Oncol; 2007 Dec; 29(4):277-80. PubMed ID: 18199983
[TBL] [Abstract][Full Text] [Related]
2. Antitumor and antimetastatic activities of vaccine prepared from cisplatin-resistant lewis lung carcinoma.
Potebnya GP; Voeykova IM; Lisovenko GS; Cheremshenko NL; Todor IM; Yudina OY; Kovtonyuk OV; Chekhun VF
Exp Oncol; 2009 Dec; 31(4):226-30. PubMed ID: 20010530
[TBL] [Abstract][Full Text] [Related]
3. Elevation of the efficacy of antitumor vaccine prepared on the base of lectines from B. subtilis B-7025 upon its combined application with probiotics in vivo.
Tanasienko OA; Cheremshenko NL; Titova GP; Potebnya MG; Gavrilenko MM; Nagorna SS; Kovalenko NK
Exp Oncol; 2005 Dec; 27(4):336-8. PubMed ID: 16404358
[TBL] [Abstract][Full Text] [Related]
4. Experimental study of the efficacy of combined use of cancer vaccine and interferon.
Potebnya GP; Kudryavets YY; Lisovenko GS; Cheremshenko NL; Voeykova IM; Trokhimenko NV; Symchich TV; Evstrateyva LM
Exp Oncol; 2007 Jun; 29(2):102-5. PubMed ID: 17704740
[TBL] [Abstract][Full Text] [Related]
5. [Influence of probiotic subalin on efficiency of antitumor vaccine].
Potebnia HP; Safronova LA; Cheremshenko NL; Lisovenko HS; Sorokulova IB; Prykhod'ko VO; Trokhymenko NV; Tanasiienko OA; Bombin AV
Mikrobiol Z; 2006; 68(6):51-8. PubMed ID: 17243367
[TBL] [Abstract][Full Text] [Related]
6. Total proteolytic activity and levels of the main proteinase inhibitors in blood plasma of mice bearing Lewis lung carcinoma upon development of resistance to cisplatin.
Chekhun VF; Kovtonyuk OV; Todor IN; Kulik GI
Exp Oncol; 2005 Dec; 27(4):286-9. PubMed ID: 16404348
[TBL] [Abstract][Full Text] [Related]
7. [Allogeneic dendritic cell vaccine pulsed with heat shocked tumor cell lysate can enhance antitumor immunity].
You J; Wang CL; Hao XS
Zhonghua Yi Xue Za Zhi; 2007 Oct; 87(39):2785-90. PubMed ID: 18167273
[TBL] [Abstract][Full Text] [Related]
8. [Treatment of murine Lewis lung cancer with recombinant interleukin-12].
Yin XL; Duan H; Peng ZP; Sun SL; Li SL
Ai Zheng; 2006 Sep; 25(9):1087-91. PubMed ID: 16965647
[TBL] [Abstract][Full Text] [Related]
9. Changes in VEGF level and tumor growth characteristics during lewis lung carcinoma progression towards cis-DDP resistance.
Pyaskovskaya ON; Dasyukevich OI; Kolesnik DL; Garmanchouk LV; Todor IN; Solyanik GI
Exp Oncol; 2007 Sep; 29(3):197-202. PubMed ID: 18004244
[TBL] [Abstract][Full Text] [Related]
10. [Antitumor effects of recombinant quail vascular endothelial growth factor receptor 2, as a vaccine, combined with cisplatin on LL/2 tumor model in mice].
Hou JM; Liu JY; Yang L; Zhao X; Tian L; Lei S; Mao YQ; Wen YJ; Wei YQ
Ai Zheng; 2005 Apr; 24(4):391-6. PubMed ID: 15820058
[TBL] [Abstract][Full Text] [Related]
11. Administration of vitamin D3 improves antimetastatic efficacy of cancer vaccine therapy of Lewis lung carcinoma.
Zhuravel E; Efanova O; Shestakova T; Glushko N; Mezhuev O; Soldatkina M; Pogrebnoy P
Exp Oncol; 2010 Mar; 32(1):33-9. PubMed ID: 20332759
[TBL] [Abstract][Full Text] [Related]
12. The therapeutic efficacy of angiostatin against weakly- and highly-immunogenic 3LL tumors.
Li M; Huang X; Zhu Z; Zhao Q; Wong M; Gorelik E
In Vivo; 2002; 16(6):577-82. PubMed ID: 12494903
[TBL] [Abstract][Full Text] [Related]
13. Potential role of transforming growth factor beta1 in drug resistance of tumor cells.
Stoika R; Yakymovych M; Souchelnytskyi S; Yakymovych I
Acta Biochim Pol; 2003; 50(2):497-508. PubMed ID: 12833174
[TBL] [Abstract][Full Text] [Related]
14. Induction of antitumor immunity by combined immunogene therapy using IL-2 and IL-12 in low antigenic Lewis lung carcinoma.
Tanaka M; Saijo Y; Sato G; Suzuki T; Tazawa R; Satoh K; Nukiwa T
Cancer Gene Ther; 2000 Nov; 7(11):1481-90. PubMed ID: 11129290
[TBL] [Abstract][Full Text] [Related]
15. PNAS-4, a novel pro-apoptotic gene, can potentiate antineoplastic effects of cisplatin.
Yuan Z; Yan F; Wang YS; Liu HY; Gou LT; Zhao XY; Lai ST; Deng HX; Li J; Ding ZY; Xiong SQ; Kan B; Mao YQ; Chen LJ; Wei YQ; Zhao X
Cancer Chemother Pharmacol; 2009 Dec; 65(1):13-25. PubMed ID: 19387645
[TBL] [Abstract][Full Text] [Related]
16. Preclinical antitumor activity of the oral platinum analog satraplatin.
Wosikowski K; Lamphere L; Unteregger G; Jung V; Kaplan F; Xu JP; Rattel B; Caligiuri M
Cancer Chemother Pharmacol; 2007 Sep; 60(4):589-600. PubMed ID: 17541592
[TBL] [Abstract][Full Text] [Related]
17. Antitumor activity of a new platinum(II) complex with low nephrotoxicity and genotoxicity.
Marzano C; Bettio F; Baccichetti F; Trevisan A; Giovagnini L; Fregona D
Chem Biol Interact; 2004 Jun; 148(1-2):37-48. PubMed ID: 15223355
[TBL] [Abstract][Full Text] [Related]
18. Superiority of interleukin-12-transduced murine lung cancer cells to GM-CSF or B7-1 (CD80) transfectants for therapeutic antitumor immunity in syngeneic immunocompetent mice.
Sumimoto H; Tani K; Nakazaki Y; Tanabe T; Hibino H; Wu MS; Izawa K; Hamada H; Asano S
Cancer Gene Ther; 1998; 5(1):29-37. PubMed ID: 9476964
[TBL] [Abstract][Full Text] [Related]
19. EFFECT OF B. SUBTILIS ІМV B-7724 LECTIN ON THE ACTIVITY OF EFFECTORS OF CELLULAR ANTITUMOR IMMUNITY OF MICE WITH LEWIS LUNG CARCINOMA.
Chumak A; Fedosova N; Cheremshenko N; Karaman O; Симчич Т; Voyeykova I
Exp Oncol; 2023 Dec; 45(3):328-336. PubMed ID: 38186022
[TBL] [Abstract][Full Text] [Related]
20. Cisplatinum and transplatinum complexes with benzyliminoether ligands; synthesis, characterization, structure-activity relationships, and in vitro and in vivo antitumor efficacy.
Sbovata SM; Bettio F; Mozzon M; Bertani R; Venzo A; Benetollo F; Michelin RA; Gandin V; Marzano C
J Med Chem; 2007 Sep; 50(19):4775-84. PubMed ID: 17713897
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
